Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2003
11/06/2003WO2003091396A2 Polypeptides and biosynthetic pathways
11/06/2003WO2003091391A2 Atherosclerotic phenotype determinative genes and methods for using the same
11/06/2003WO2003091282A1 Histamine receptor h3 ordinary activity mutant and utilization thereof
11/06/2003WO2003091279A2 COMBINATION VACCINES INCLUDING IMMUNOGENIC GapC AND CAMP FACTOR POLYPEPTIDES
11/06/2003WO2003091271A1 Alternatively spliced nucleic acid molecules
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003090788A1 DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
11/06/2003WO2003090515A2 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation
11/06/2003WO2003090514A2 Adipocyte complement related protein zacrp14
11/06/2003WO2003074700A3 Transposon
11/06/2003WO2003070898A3 Selective extraction of dna from groups of cells
11/06/2003WO2003054153A3 Apyrase polypeptides and nucleic acids encoding same
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003020885B1 Identification of sortase gene
11/06/2003WO2003015714A3 Compositions and therapeutic methods for viral infection
11/06/2003WO2003012069A3 Compositions and methods for generating chimeric heteromultimers
11/06/2003WO2003008588A3 Method for producing 2-keto-l-gulonic acid and vitamin c while using l-sorbose dehydrogenase and l-sorbosone dehydrogenase
11/06/2003WO2003006664A3 Process for the preparation of d-pantothenic acid and/or salts thereof
11/06/2003WO2003006602A3 Subtilase variants
11/06/2003WO2003006496A3 Protein variants of neocarzinostatine and its homologues and their use
11/06/2003WO2003003906A3 Diagnostic and screening methods for bladder cancer
11/06/2003WO2003002604A3 G protein coupled receptors and dna sequences thereof
11/06/2003WO2002102318A3 Eglin c based drugs for treatment of disease
11/06/2003WO2002090523A3 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid
11/06/2003WO2002086126A3 Enzymatic method for the enantioselective reduction of keto compounds
11/06/2003WO2002083854A9 Antibodies to vla-1
11/06/2003WO2002083711A3 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
11/06/2003WO2002066662A8 Process for the preparation of perillyl alcohol
11/06/2003WO2002066649A8 ANTI-INTERFERON-α ANTIBODIES
11/06/2003WO2002062945A3 Compositions and methods relating to lung specific genes and proteins
11/06/2003WO2002061115A3 Method for the evolutionary design of biochemical reaction networks
11/06/2003WO2002061105A3 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
11/06/2003WO2002061070A8 Environmentally regulated genes, involved in the virulence of streptococcus suis
11/06/2003WO2002059312A3 Cell adhesion proteins
11/06/2003WO2002059266A3 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002050260A3 Process for the production and purification of secreted proteins ans the production of arrays of proteins
11/06/2003WO2002046475A3 Method of detecting and treating tuberous sclerosis complex associated disorders
11/06/2003WO2002046437A3 Methods and compositions for highly efficient production of heterologous proteins in yeast
11/06/2003WO2002046379A3 Glucuronyl c5-epimerase, dna encoding the same and uses thereof
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002044199A3 Neurotoxins with enhanced target specificity
11/06/2003WO2002026933A3 Isoprenoid production
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2002024883A3 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
11/06/2003US20030208796 Method for producing mushroom mycelia and uses thereof
11/06/2003US20030208783 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208054 Fc Receptors and polypeptides
11/06/2003US20030208041 Chloride channel polypeptides and nucleic acids, and their uses in obtaining compounds for preventing or treating a tick infestation
11/06/2003US20030208039 Use of antibodies encompass procedures for diagnostic and prognostic assay of the polypeptides, as well as methods of treating diverse pathological conditions
11/06/2003US20030208029 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same
11/06/2003US20030207947 Production of lutein in microorganisms
11/06/2003US20030207806 Insecticidal protein toxins from Photorhabdus
11/06/2003US20030207795 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/06/2003US20030207446 Infectious papillomavirus pseudoviral particles
11/06/2003US20030207437 Preparation of acariogenic sugar substitutes
11/06/2003US20030207436 From an N-acyl-D-amino acid, wherein a minimum reaction rate is specified when forming D-tryptophan from N-acetyl-D-tryptophan in an aqueous medium
11/06/2003US20030207435 Have increased anti-coagulation activity and resistance to inactivation by serpins
11/06/2003US20030207434 Phosphodiesterases
11/06/2003US20030207412 Method of producing polyhydroxyalkanoate from alkane having residue containing aromatic ring in its molecule
11/06/2003US20030207411 DNA sequence encoding enzymes of clavulanic acid biosynthesis
11/06/2003US20030207410 Process for the biological production of l-pipecolic acid
11/06/2003US20030207408 Converting maltogenic alpha-amylase into a cyclodextrin glucanotransferase (CGTase) or vice versa or creating hybrids of the two
11/06/2003US20030207406 Method of transferring at least two saccharide units with a polyglycosyltransferase
11/06/2003US20030207405 Reacting a sugar phosphate and cytosine or cytosine derivative in the presence of an enzyme having the activity of cytosine nucleoside phosphorylase; given amino acid sequence; little by-product
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207402 Simple production and high yield
11/06/2003US20030207401 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207380 For diagnosis and treatment of estrogenic disorder of mutant ER alpha
11/06/2003US20030207347 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation
11/06/2003US20030207340 For diagnosis of cancer
11/06/2003US20030207339 PCAM-1 marker protein, nucleic acid sequences encoding PCAM-1 and immunoassays for detection of PCAM-1
11/06/2003US20030207327 Eukaryotic cells engineered to differ by as few as one encoded amino acid at a defined target locus; for therapeutic and pharmacogenic use
11/06/2003US20030207322 Nucleic acid encoding toluene monooxygenase enzyme pathway; transformed host cells for biosynthesis of p-hydroxybenzoic acid
11/06/2003US20030207321 Nucleic acid fragments for the identification of bacteria in industrial wastewater bioreactors
11/06/2003US20030207320 Diagnostic for organisms key to health of activated sludge wastewater systems
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207317 Novel nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use
11/06/2003US20030207301 Assay for the detection of factors that modulate the expression of INGAP
11/06/2003US20030207299 Involves nucleic acid and amino acid sequences of human kinases; used in the diagnosis, treatment, and prevention of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders
11/06/2003US20030207293 Cryptic-like secreted protein
11/06/2003US20030207271 Methods and compositions for biological sensors
11/06/2003US20030207264 Use of a single fluorophore rather than an "acceptor-donor" fluoresecence resonance energy transfer system offers synthesis and performance advantages; fluorogenic protease indicators
11/06/2003US20030207260 Contacted with probe that hybridizes one complementary sequence
11/06/2003US20030206922 Siderophore receptor polypeptides (SRPs) and porins from gram negative microbes and no greater than 10.0 endotoxin units per milliliter lipopolysaccharide; or SRPs isolated from a gram positive microbe; treating infectious diseases in cattle
11/06/2003US20030206921 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/06/2003US20030206920 Proteinic product, process for its preparation, compositions containing it and use in medicaments
11/06/2003US20030206900 Vectors derived from antibodies for transferring substances into cells
11/06/2003CA2484079A1 Expression systems for stem-loop rna molecule having rnai effect
11/06/2003CA2483701A1 Constitutively active histamine h3 receptor mutants and uses thereof
11/06/2003CA2483564A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003CA2483513A1 Reporter-selectable hepatitis c virus replicon
11/06/2003CA2483453A1 Combination vaccines including immunogenic gapc and camp factor polypeptides
11/06/2003CA2483431A1 Alternatively spliced nucleic acid molecules
11/06/2003CA2483337A1 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003CA2483126A1 Polypeptides and biosynthetic pathways for the production of monatin
11/06/2003CA2483106A1 Decoys for treating and/or preventing th2 cytokine-related allergic diseases, gata3 mutant proteins and, pharmaceutical compositions comprising the decoys and the proteins
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
1 ... 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 ... 1489